Form 4: Progyny CFO Sells Shares Under 10b5-1 Plan

Progyny's Chief Financial Officer, Mark S. Livingston, reported the sale of company common stock and shares withheld for taxes, both executed under a pre-arranged 10b5-1 trading plan.

Summary

• Mark S. Livingston, Chief Financial Officer of Progyny, Inc., reported transactions involving the company's common stock.
• On December 2, 2025, 224 shares were disposed of at a price of $25.27 per share. These shares were withheld for the payment of withholding taxes upon the vesting of restricted stock units.
• On the same date, an additional 213 shares were sold at $25.50 per share. This sale was conducted pursuant to a Rule 10b5-1 trading plan, which was established on August 15, 2025.
• Following these reported transactions, Mr. Livingston beneficially owns 47,921 shares of Progyny common stock.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions, specifically sales for tax withholding and a pre-planned sale under a 10b5-1 plan. These are generally neutral events and do not indicate a significant positive or negative sentiment regarding the company's prospects.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing details routine insider transactions by a key executive and does not provide broader industry context or trends. Such transactions are common for executives managing their equity compensation and personal financial planning.

Related Party Transactions

• Mark S. Livingston, the Chief Financial Officer, engaged in transactions involving company common stock, which are considered related party transactions due to his executive position.

Stakeholder Impact

• Shareholders: The sale of a relatively small number of shares by a CFO under a pre-planned 10b5-1 program is unlikely to have a material impact on existing shareholders, as it is a routine event for executive compensation management.

Key Dates

Recommendation

The Form 4 filing details routine insider stock sales by the CFO, primarily for tax withholding and under a pre-established 10b5-1 trading plan. These transactions are generally considered non-eventful and do not provide new fundamental information about Progyny's operational performance or future prospects. Therefore, based solely on this filing, there is no new information to warrant a change from a 'hold' position.

Keywords

Progyny, PGNY, Form 4, Insider Trading, Mark S. Livingston, CFO, Stock Sale, 10b5-1 Plan, Restricted Stock Units, Equity Compensation